Lebanon may be blacklisted for not enforcing pharmaceutical patents
►http://www.dailystar.com.lb/Business/Lebanon/2012/Apr-03/168963-lebanon-may-be-blacklisted-for-not-enforcing-pharmaceutical-pat
The Pharmaceutical Research and Manufacturers of America (PhRMA) has asked the United States Trade Representative to include Lebanon on the 2012 Priority Watch List due to the lack of adequate intellectual property protection in the Lebanese pharmaceutical market.
Lebanon is one of 17 countries, in addition to the European Union, that PhRMA – an organization grouping the largest U.S. pharmaceutical companies – recommended for the Priority Watch List, according to Lebanon This Week, the economic publication of the Byblos Bank Group. The list includes Algeria and Israel from the region.
PhRMA identified ineffective regulatory data protection, regulatory barriers and parallel imports as the three key issues of concern in the Lebanese pharmaceutical market.